An Early Phase 1 interventional study of Caudal epidural injection and Caudal Epidural Injection with generic Celestone in Low Back Pain, sponsored by Pain Management Center of Paducah. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-08-16.
Sponsored by Pain Management Center of Paducah · Early Phase 1, Interventional, and Treatment
To demonstrate clinically significant improvements or lack thereof in the caudal epidural patients with our without steroids.
To evaluate differences in outcomes in patients receiving steroids compared to those patients randomized to the local anesthetic group who did not receive steroids.
To assess improvements among patients and compare steroid groups with each other and local anesthetic group.
To evaluate and compare the adverse event profile in all patients
Patients with chronic low back pain of at least 6 months duration, non-responsive to conservative management with NSAIDS, physical therapy or chiropractic treatment exercises.
A single-center, prospective, controlled, double blinded, randomized study of patients in 4 groups.
All patients will be unblinded in 12 months.
Non-responsive patients will be unblinded after 3 months and will be crossed over to a different group
2,818 studies on the registry are indexed under Low Back Pain; 482 are open to participants now.
This study's enrollment of 240 is above the median of 60 across 2,268 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →Pain Management Center of Paducah is the lead sponsor of 14 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Group 1. local anesthetics only
Drug: Caudal epidural injection
Group 2. local anesthetic with 6mg of non-particulate Celestone
Drug: Caudal Epidural Injection with generic Celestone
Group 3. local anesthetic with 6 mg of brand nameCelestone
Drug: Caudal Epidural Injection with Celestone
Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol
Drug: Caudal Epidural Injection with DepoMedrol
group 1: Caudal epidural injection local anesthetics only
Also known as: Group 1
Group 2. Caudal Epidural Injection local anesthetic with 6mg of non-particulate Celestone
Also known as: Group 2
Group 3. Caudal Epidural Injection with local anesthetic with 6 mg of brand name Celestone
Also known as: Group 3
Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol
Also known as: Group 4
To evaluate for differences between the patients in various groups in the physical function and pain at 1, 3, 6, and 12 months post treatment
Time frame: 1,3,6,12 months
To assess adverse events in all four groups.
Time frame: 1,3,6,12 months
This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pain Management Center of Paducah